Pharma exporters eye ‘preferential treatment’ by US

The US will impose reciprocal tariffs on Indian exports from April 2, causing mixed reactions from the domestic pharma sector. The industry hopes for preferential treatment from the Trump administration due to low-cost generics benefiting US consumers. Indian pharma accounts for 5.6% of US imports and supplies the most low-cost generics.